Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Tight regulation of transcription factors, such as PU.1, is crucial for generation of all hematopoietic lineages. We previously reported that mice with a deletion of an upstream regulatory element (URE) of the gene encoding PU.1 (Sfpi1) developed acute myeloid leukemia. Here we show that the URE has an essential role in orchestrating the dynamic PU.1 expression pattern required for lymphoid development and tumor suppression. URE deletion ablated B2 cells but stimulated growth of B1 cells in mice. The URE was a PU.1 enhancer in B cells but a repressor in T cell precursors. TCF transcription factors coordinated this repressor function and linked PU.1 to Wnt signaling. Failure of appropriate PU.1 repression in T cell progenitors with URE deletion disrupted differentiation and induced thymic transformation. Genome-wide DNA methylation assessment showed that epigenetic silencing of selective tumor suppressor genes completed PU.1-initiated transformation of lymphoid progenitors with URE deletion. These results elucidate how a single transcription factor, PU.1, through the cell context-specific activity of a key cis-regulatory element, affects the development of multiple cell lineages and can induce cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an upstream regulatory element of PU.1 functions as a PU.1 enhancer in B cells but as a repressor in T-cell precursors.30”
From PELI2 regulates early B-cell progenitor differentiation and related leukemia via the IL-7R expression (2023) · cites this paper as [30]
In the citing paper
“The best current candidates for this silencing activity include GATA-3 (104, 105), TCF-1 or LEF-1 (37), and especially Runx1 (80, 150–152), probably working in a dose-dependent combination, although the mechanism through which they finally achieve the ability to repress PU.1 has not yet been reported.”
From Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development (2019) · cites this paper as [37]
In the citing paper
“PU.1 is crucial for lymphomyeloid development, and its stage-specific expression is critical in preventing leukemic transformation.1,2”
From Macrophage development from HSCs requires PU.1-coordinated microRNA expression (2011) · cites this paper as [1]
In the citing paper
“in the erythroid lineage, in which SPI1 exerts an oncogenic function by blocking differentiation.”
From HDAC1 and PRC2 mediate combinatorial control in SPI1/PU.1-dependent gene repression in murine erythroleukaemia (2022) · cites this paper as [20]
Citations
Cites
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253 · cited 1×
“A hierarchical model has been established in which hematopoietic stem cells (HSCs) give rise to common lymphoid progenitor cells (CLPs), which are believed to manifest the earliest representatives of all lymphocyte”
BackgroundSelf-citationA role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · cited 1×
“Sfpi1 -null mice undergo early lethality and lack B-lymphocytes and mature myeloid cells in fetal liver”
BackgroundAberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
Self-citationIntestinal polyposis in mice with a dominant stable mutation of the beta -catenin gene
Harada, N. (1999) · The EMBO Journal · doi:10.1093/emboj/18.21.5931 · Cited by 1,212
High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP
Rodríguez, C. I., Buchholz, F., Galloway, J., Sequerra, R., Kasper, J., Ayala, R., Stewart, A. F., & Dymecki, S. M. (2000) · Nature Genetics · doi:10.1038/75973 · Cited by 1,159
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
Induction of T Cell Development from Hematopoietic Progenitor Cells by Delta-like-1 In Vitro
Schmitt, T. M., & Zúñiga-Pflücker, J. C. (2002) · Immunity · doi:10.1016/s1074-7613(02)00474-0 · Cited by 1,120 · cited 1×
“We established the T cell line from a UREΔ mouse by culturing primary thymic lymphoma cells on OP9-DL1 stroma layer”
Method
Cited by
Items 101–200 of 240
Skokowa, J., Fobiwe, J. P., Lan, D., Thakur, B. K., & Welte, K. (2009) · Blood · doi:10.1182/blood-2008-11-188755 · Cited by 37
Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia
Sonnet, M., Claus, R., Becker, N., Zucknick, M., Petersen, J., Lipka, D. B., Oakes, C. C., Andrulis, M., Lier, A., Milsom, M. D., et al. (2014) · Genome Medicine · doi:10.1186/gm551 · Cited by 37
Self-citationPU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4
Ueno, N., Nishimura, N., Ueno, S., Endo, S., Tatetsu, H., Hirata, S., Hata, H., Matsuoka, M., Mitsuya, H., & Okuno, Y. (2017) · Oncogene · doi:10.1038/onc.2017.79 · Cited by 34
Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia
Aue, G., Du, Y., Cleveland, S. M., Smith, S. B., Davé, U. P., Liu, D., Weniger, M. A., Metais, J. Y., Jenkins, N. A., Copeland, N. G., et al. (2011) · Blood · doi:10.1182/blood-2011-04-351528 · Cited by 36
Heterozygous deletion of the PU.1 locus in human AML
Bonadies, N., Pabst, T., & Mueller, B. U. (2010) · Blood · doi:10.1182/blood-2009-03-212225 · Cited by 33
Fang, S., Huang, S.-F., Cao, J., Wen, Y., Zhang, L., & Ren, G.-S. (2012) · Clinical and Experimental Medicine · doi:10.1007/s10238-012-0182-9 · Cited by 33
Bresnick, E. H., & Johnson, K. D. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000378 · Cited by 34
“1 levels are regulated by an enhancer 14 kb upstream of the Spi1 promoter (upstream regulatory element [URE]).(114,116,117) Unlike 19.”
BackgroundWille, C. K., Li, Y., Rui, L., Johannsen, E., & Kenney, S. C. (2016) · Journal of Virology · doi:10.1128/jvi.01987-16 · Cited by 33
“1 also functions as a tumor 473 suppressor during later stages of B cell development and is often turned off in certain B cell 474 malignancies (50, 51).”
BackgroundSkokowa, J., & Welte, K. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04963.x · Cited by 32
Spi-C Has Opposing Effects to PU.1 on Gene Expression in Progenitor B Cells
Schweitzer, B. L., Huang, K. J., Kamath, M. B., Emelyanov, A. V., Birshtein, B. K., & DeKoter, R. P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2195 · Cited by 33
“1 gene eliminates B-2 cells, but enhances the B-1 cell population (58).”
BackgroundXu, L., Sokalski, K. M., Hotke, K., Christie, D. A., Zarnett, O. J., Piskorz, J., Thillainadesan, G., Torchia, J., & DeKoter, R. P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201267 · Cited by 32
“1 has also been implicated as a cause of T cell leukemia in genetically modified mice (43).”
BackgroundPU.1 Activates Transcription of SHP-1 Gene in Hematopoietic Cells
Wlodarski, P., Zhang, Q., Liu, X., Kasprzycka, M., Marzec, M., & Wasik, M. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607526200 · Cited by 29
Kim, B., Dabin, L. C., Tate, M. D., Karahan, H., Sharify, A. D., Acri, D. J., Al-Amin, M. M., Philtjens, S., Smith, D. C., Wijeratne, H. R. S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48484-x · Cited by 28
“Forexample, Camk2a,Camk2n1,H2-D1,Olfml3 , and Qpct were upregulated in microglial clusters 4 and 10, while H2-DMa was downregulated in microglial clusters 1,2,3,4,5,6, and 9 (Supplementary Data 12).”
Rathinam, C., & Klein, C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000306 · Cited by 28
RetractedNfix Expression Critically Modulates Early B Lymphopoiesis and Myelopoiesis
O’Connor, C., Campos, J., Osinski, J. M., Gronostajski, R. M., Michie, A. M., & Keeshan, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120102 · Cited by 31
“1 expression levels are important in the determination of lineage fate [33,34].”
Gregoricchio, S., Polit, L., Esposito, M., Berthelet, J., Delestré, L., Evanno, E., Diop, M., Gallais, I., Aleth, H., Poplineau, M., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac613 · Cited by 27
Self-citationBonifer, C., Hoogenkamp, M., Krysinska, H., & Tagoh, H. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.05.001 · Cited by 27
The Role of miRNA in Haematological Malignancy
Gounaris-Shannon, S., & Chevassut, T. J. T. (2013) · Bone Marrow Research · doi:10.1155/2013/269107 · Cited by 30
“…a loose association between certain haematological cancers and aberrantmiRNA expression, others have been able to illustrate their role as oncogenic or tumour suppressors in nature through validation of cancer associated targets, and these miRNAs will primarily be the focus of this review.”
BackgroundAlsayegh, K. N., Cortés-Medina, L. V., Ramos‐Mandujano, G., Badraiq, H., & Li, M. (2019) · Current Genomics · doi:10.2174/1389202920666191017163837 · Cited by 27
Borghesi, L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400936 · Cited by 29
“1 distal enhancer are mechanistically linked to acute myeloid leukemia (31, 62).”
BackgroundTo B1a or not to B1a: do hematopoietic stem cells contribute to tissue-resident immune cells?
Beaudin, A. E., & Forsberg, E. C. (2016) · Blood · doi:10.1182/blood-2016-10-697813 · Cited by 28
Soodgupta, D., White, L. S., Yang, W., Johnston, R., Andrews, J. M., Kohyama, M., MURPHY, K. M. M., Mosammaparast, N., Payton, J. E., & Bednarski, J. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.026 · Cited by 27
The ontogeny of murine B-1a cells
Yoshimoto, M. (2019) · International Journal of Hematology · doi:10.1007/s12185-019-02787-8 · Cited by 28
OSTM1 Bone Defect Reveals an Intercellular Hematopoietic Crosstalk
Pata, M., Héraud, C., & Vacher, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805242200 · Cited by 32
Defective G-CSFR Signaling Pathways in Congenital Neutropenia
Skokowa, J., & Welte, K. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.11.001 · Cited by 26
“1 expression.(14) Thus, a lack of LEF-1 in myeloid cells of CN patients could cause up-regulation of PU.”
BackgroundJian, W., Yan, B., Huang, S., & Qiu, Y. (2017) · The FASEB Journal · doi:10.1096/fj.201700022r · Cited by 23
Burda, P., Vargova, J., Čuřík, N., Šálek, C., Papadopoulos, G. L., Strouboulis, J., & Stopka, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152234 · Cited by 27
Willcockson, M. A., Taylor, S. J., Ghosh, S., Healton, S. E., Wheat, J. C., Wilson, T. J., Steidl, U. G., & Skoultchi, A. I. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901122116 · Cited by 26
“1 (20), and mice lacking the URE exhibit disrupted T cell development, demonstrating key cell-type–specific differences in URE activity.”
BackgroundSelf-citationStage-specific action of Runx1 and GATA3 controls silencing of PU.1 expression in mouse pro–T cells
Hosokawa, H., Koizumi, M., Masuhara, K., Romero-Wolf, M., Tanaka, T., Nakayama, T., & Rothenberg, E. V. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202648 · Cited by 24
“, 2005), showed enhancer activity in myeloid and B cells (Rosenbauer et al., 2006; Rosenbauer et al., 2004), while its T lineage role appeared bivalent or repressive (Hoogenkamp et al.”
BackgroundInfluentialHTLV-I p30: A versatile protein modulating virus replication and pathogenesis
Bai, X. T., Baydoun, H. H., & Nicot, C. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.05.004 · Cited by 23
“Recent evidence indicates that graded reduction in the expression of PU.1 in CD34+ derived bone marrow stem cells led to an intermediate stage of a poorly differentiated pre-leukemic cell population, which, with the accumulation of additional genetic mutations, resulted in an aggressive form of acute myeloid leukemia…”
BackgroundTargeting the Wnt Pathway in Cancer
Goss, K. H., & Kahn, M. R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8023-6 · Cited by 24
DNA selection by the master transcription factor PU.1
Terrell, J. R., Taylor, S. J., Schneider, A. L., Lu, Y., Vernon, T. N., Xhani, S., Gumpper, R. H., Luo, M., Wilson, W. D., Steidl, U. G., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112671 · Cited by 25
Self-citationPU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL.
Ueno, S., Tatetsu, H., Hata, H., Iino, T., Niiro, H., Akashi, K., Tenen, D. G., Mitsuya, H., & Okuno, Y. (2009) · Oncogene · doi:10.1038/onc.2009.263 · Cited by 20
“E-mail: yokuno@gpo.kumamoto-u.ac.jp Oncogene (2009) 28, 4116–4125 & 2009 Macmillan Publishers Limited All rights reserved 0950-9232/09 $32.00 www.nature.com/onc 50-upstream region has suppressor activity for PU.1 expression in the T-cell lineage through wnt signaling (Rosenbauer et al., 2006).”
BackgroundSelf-citationRegner, M. J., García‐Recio, S., Thennavan, A., Wiśniewska, K., Méndez-Giráldez, R., Felsheim, B., Spanheimer, P. M., Parker, J. S., Perou, C. M., & Franco, H. L. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100765 · Cited by 28
Thillo, Q. V., Bie, J. D., Seneviratne, J. A., Demeyer, S., Omari, S. A., Balachandran, A., Zhai, V., Tam, W. L., Sweron, B., Geerdens, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24442-9 · Cited by 21
The role of long non‐coding RNAs and downstream signaling pathways in leukemia progression
Liu, Y., Sun, P., Zhao, Y., & Liu, B. (2020) · Hematological Oncology · doi:10.1002/hon.2776 · Cited by 26
“1, is associated with malignant transformation.(100)”
Temporal autoregulation during human PU.1 locus SubTAD formation
Schuetzmann, D., Walter, C., van Riel, B., Kruse, S., König, T., Erdmann, T., Tönges, A., Bindels, E. M., Weilemann, A., Gebhard, C., et al. (2018) · Blood · doi:10.1182/blood-2018-02-834721 · Cited by 20
Self-citationMyeloid leukemia with transdifferentiation plasticity developing from T‐cell progenitors
Riemke, P., Czéh, M., Fischer, J., Walter, C., Ghani, S., Zepper, M., Agelopoulos, K., Lettermann, S., Gebhardt, M. L., Mah, N., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201693927 · Cited by 20
“Protein samples were prepared as described in Rosenbauer et al (2006).”
Self-citationEpigenetic therapy as a novel approach for GFI136N-associated murine/human AML
Botezatu, L., Michel, L., Helness, A., Vadnais, C., Makishima, H., Hönes, J. M., Robert, F., Vaßen, L., Thivakaran, A., Al-Matary, Y. S., et al. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.05.004 · Cited by 22
Guo, H. W., Barberi, T. J., Suresh, R., & Friedman, A. D. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800244 · Cited by 18
Montecino-Rodriguez, E., Casero, D., Fice, M., Le, J., & Dorshkind, K. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701336 · Cited by 17
“2B, 2C), it is likely that the cells analyzed in the previous study (20) were non–T lineage cells able to express Spi1 independently of the 14-kb URE (35).”
BackgroundResultInfluentialÁlvarez-Arzola, R., Oliver, L., Valdés, A. F.-C., & Mesa, C. (2018) · Seminars in Oncology · doi:10.1053/j.seminoncol.2018.05.001 · Cited by 18
Dynamic control of the T-cell specification gene regulatory network
Rothenberg, E. V. (2019) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2019.10.012 · Cited by 17
The layered development of mouse B and T Cells
Montecino‐Rodriguez, E., & Dorshkind, K. A. (2022) · Immunological Reviews · doi:10.1111/imr.13181 · Cited by 18
Seshire, A., Rößiger, T., Frech, M., Beez, S., Hagemeyer, H., & Puccetti, E. (2011) · Leukemia · doi:10.1038/leu.2011.331 · Cited by 17
Endo, S., Amano, M., Nishimura, N., Ueno, N., Ueno, S., Yuki, H., Fujiwara, S., Wada, N. A., Hirata, S., Hata, H., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.11.116 · Cited by 16
Core-binding factor leukemia hijacks the T-cell–prone PU.1 antisense promoter
van der Kouwe, E., Heller, G., Czibere, A. G., Pulikkan, J. A., Agreiter, C., Castilla, L. H., Delwel, R., Ruscio, A. D., Ebralidze, A. K., Forte, M., et al. (2021) · Blood · doi:10.1182/blood.2020008971 · Cited by 18
Self-citationRegulatory factors for initial T lymphocyte lineage specification
Rothenberg, E. V. (2007) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3281de72a8 · Cited by 18
Walker, M., Li, Y., Morales‐Hernández, A., Qi, Q., Parupalli, C., Brown, S., Christian, C. M., Clements, W. K., Cheng, Y., & McKinney‐Freeman, S. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022007811 · Cited by 17
Huseby, E. S., & Teixeiro, E. (2022) · Science Signaling · doi:10.1126/scisignal.abj9842 · Cited by 16
Rothenberg, E. V., Champhekar, A. S., Damle, S. S., Real, M. M. D., Kueh, H. Y., Li, L., & Yui, M. A. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020271 · Cited by 17
“…Tal1, Lyl1, and Lmo2 is a major contributor to T-cell malignancy, whereas Erg, Hhex, Mef2c, and Sfpi1 deregulation can also promote malignancy (Palomero et al. 2006; Rosenbauer et al. 2006; Zhong et al. 2007; McCormack et al. 2010; Tremblay et al. 2010; Homminga et al. 2011; Thoms et al. 2011).”
BackgroundEdrei, Y., Levy, R., Kaye, D., Marom, A., Radlwimmer, B., & Hellman, A. (2023) · Genome biology · doi:10.1186/s13059-023-03094-6 · Cited by 12
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype
Galera, P. K., Dilip, D., Derkach, A., Chan, A. C. L., Zhang, Y., Persaud, S., Mishra, T., Kramer, K., Kathpalia, M., Liu, Y., et al. (2025) · Blood · doi:10.1182/blood.2024026273 · Cited by 14
Perspectives of proteomics in acute myeloid leukemia
Czibere, A. G., Grall, F. T., & Aivado, M. A. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.11.1663 · Cited by 11
Pin1‐Mediated Prolyl Isomerization of Runx1 Affects PU.1 Expression in Pre‐Monocytes
Islam, R., Yoon, W., Woo, K. M., Baek, J., & Ryoo, H. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24462 · Cited by 11
“1 expression within hematopoietic cells (Rosenbauer et al., 2006).”
ANP32B suppresses B‐cell acute lymphoblastic leukemia through activation of PU .1 in mice
Yang, Q., Liu, H., Yang, S., Wei, Y., Zhu, X., Zhi, Z., Zhu, D., Chen, G., & Yu, Y. (2023) · Cancer Science · doi:10.1111/cas.15822 · Cited by 11
Xi, H.-M., Lu, H., Weng, X., Sheng, Y., Wu, J. Y., Li, L., & Cai, X. (2023) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520623666230110121629 · Cited by 10
Goto, H., Kariya, R., Kudo, E., Okuno, Y., Ueda, K., Katano, H., & Okada, S. (2017) · Oncogene · doi:10.1038/onc.2017.138 · Cited by 10
Transcriptional Activation of the Pirb Gene in B Cells by PU.1 and Runx3
Arita, K., Endo, S., Kaifu, T., Kitaguchi, K., Nakamura, A., Ohmori, H., Kohu, K., Satake, M., & Takai, T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001302 · Cited by 12
“1 due to a deletion in its enhancer region lack B-2 cells, whereas the proliferation of B-1 cells in these mice was rather accelerated (44).”
BackgroundKorczmar, E., Bookstaver, A. K., Ober, E., Goldfarb, A. N., Tenen, D. G., & Trinh, B. Q. (2024) · Frontiers in Bioscience-Scholar · doi:10.31083/j.fbs1602010 · Cited by 9
“Its expression is relatively high in CLPs and early thymic progenitors (ETPs) but fully extinguished in mature T cells [6,24].”
BackgroundMethodInfluentialSelf-citationPromoter sequence variants of LIGHT are associated with female vascular dementia
Kong, M., Kim, Y., & Lee, C. (2008) · Journal of Biomedical Science · doi:10.1007/s11373-008-9242-2 · Cited by 8
“For example, T-cell factor/lymphoid enhancer-binding factor (TCF/LEF) is known as a transcriptional activator essential for lymphoid cell development [20].”
BackgroundKronenberger, K., Nöβner, E., Frankenberger, B., Wahl, U., Dreyling, M. H., Hallek, M. J., & Mocikat, R. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318183af26 · Cited by 8
“1 that is overexpressed in several other neoplasias.(23) The antiapoptotic gene Bcl-xL and the proapoptotic gene Atm were only slightly up-regulated.”
BackgroundManesso, E., Kueh, H. Y., Freedman, G., Rothenberg, E. V., & Peterson, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161260 · Cited by 9
Multiple Curricula for B Cell Developmental Programming
Rothenberg, E. V. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.005 · Cited by 8
“A highly conserved enhancer controlling the PU.1 gene (Spi1) is critical for its maximal expression and its proper regulation in lymphocytes (Rosenbauer et al., 2006).”
BackgroundTransient PU.1 low fetal progenitors generate lymphoid progeny that contribute to adult immunity
Montecino‐Rodriguez, E., Estrada, O. I., & Dorshkind, K. A. (2024) · Life Science Alliance · doi:10.26508/lsa.202402629 · Cited by 7
Qiu, K., Vu, D. C., Wang, L., Nguyen, N. N., Bookstaver, A. K., Sol‐Church, K., Li, H., Dinh, T. N., Goldfarb, A. N., Tenen, D. G., et al. (2024) · Epigenetics & Chromatin · doi:10.1186/s13072-024-00556-4 · Cited by 7
“Among PCREs, the URE has been demonstrated to be bifunctional as an enhancer in myeloid cells and a silencer in T cells [8, 16–18].”
BackgroundMethodInfluentialSelf-citationRothenberg, E. V., & Göttgens, B. (2020) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000628 · Cited by 6
Hosokawa, H., Masuhara, K., & Koizumi, M. (2021) · BioEssays · doi:10.1002/bies.202000345 · Cited by 7
Ferguson, R., Archambault, A. N., Simpson, D., Morales, L. J., Chat, V., Kazlow, E., Lax, R., Yoon, G. H., Moran, U., Shapiro, R. L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46665-z · Cited by 6
Zeng, M. N., Ma, W. L., & Zheng, W. (2016) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2016.07.009 · Cited by 6
“[17] Rosenbauer F, Owens BM, Yu L, et al.”
BackgroundWheat, J. C., & Steidl, U. G. (2021) · Blood · doi:10.1182/blood.2019004261 · Cited by 6
Self-citationMontecino‐Rodriguez, E., & Dorshkind, K. A. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.104860 · Cited by 4
The PU.1 transcription factor induces cyclin D2 expression in U937 cells
Vicari, L., Eramo, A., Manzella, L., Malaguarnera, L., Iannolo, G., Gulisano, M., Maria, R. D., Messina, A., & Vigneri, P. G. (2006) · Leukemia · doi:10.1038/sj.leu.2404447 · Cited by 4
Single-nucleus chromatin landscape dataset of mouse brain development and aging
Ma, Y., Guo, S., Chen, Y., Peng, Y., Su, X., Jiang, H., Lin, X., & Zhang, J. (2024) · Scientific Data · doi:10.1038/s41597-024-03382-1 · Cited by 4
Xu, Y., Zhou, Q., Wang, X., Zhang, A., Qi, W., Li, Y., Zheng, C., Guan, J., Sun, T., Li, J., et al. (2023) · Haematologica · doi:10.3324/haematol.2023.284041 · Cited by 3
Bone Loss and TLR4 Signals Contribute Independently to B Lineage Aging
Baker, E., Montecino‐Rodriguez, E., Xu, S., Tetradis, S., Rouault, A., Estrada, O. I., & Dorshkind, K. A. (2025) · Aging Cell · doi:10.1111/acel.70267 · Cited by 3
Wang, F., Gonzalez, L., Lian, Q., Hammond, C. A., Lau, Y. Y. M., Simons, B. D., Hirst, M., & Eaves, C. J. (2025) · Blood · doi:10.1182/blood.2024026936 · Cited by 3
Ganuza, M., & Yoshimoto, M. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.105352 · Cited by 4
Decreased PU.1 expression in mature B cells induces lymphomagenesis
Endo, S., Nishimura, N., Toyoda, K., Komohara, Y., Carreras, J., Yuki, H., Shichijo, T., Ueno, S., Ueno, N., Hirata, S., et al. (2024) · Cancer Science · doi:10.1111/cas.16344 · Cited by 4
Self-citationJin, H., Zhang, W., Liu, H., & Bao, Y. (2023) · BMC Genomics · doi:10.1186/s12864-023-09731-5 · Cited by 3
“The SPI subfamily genes are known to play roles in B cell development [29, 30] and the maintenance of homeostasis in Red pulp macrophages [31].”
Core binding factor leukemia hijacks T-cell prone PU.1 antisense promoterPreprint
van der Kouwe, E., Heller, G., Czibere, A., Castilla, L. H., Delwel, R., Ruscio, A. D., Ebralidze, A. K., Forte, M., Kazianka, L., Kornauth, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.29.120857 · Cited by 3
Self-citationGalera, P. K., Dilip, D., Derkach, A., Chan, A. C. L., Zhang, Y., Persuad, S., Mishera, T., Liu, Y., Famulare, C. A., Gao, Q., et al. (2023) · medRxiv · doi:10.1101/2023.11.01.23297696 · Cited by 3
Retroviral integration sites (RIS) mark cis-regulatory elements
Ng, C. E. L., Ito, Y., & Osato, M. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.10.008 · Cited by 2
“1 enhancer in B cells but a repressor in T cell precursors [58].”
BackgroundMorgan, G., Liddiard, K., Pearn, L., Pumford, S. L., Burnett, A. K., Darley, R. L., & Tonks, A. (2013) · Leukemia · doi:10.1038/leu.2013.96 · Cited by 2
Batista, C. R., & DeKoter, R. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101960 · Cited by 2
Sleapnicov, N., Ha, S.-D., Zhong, S. J., Duchscher, J., Ezra, S., Li, S. S. ‐., & Kim, S. O. (2025) · Cancers · doi:10.3390/cancers17162684 · Cited by 1
“This dynamics in PU.1 expression is crucial for avoiding T cell malignancy [72].”
Transcription Factors in Cancer Stem Cells of the Hematopoietic Lineage
Koschmieder, S., & Tenen, D. G. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-933-8_6 · Cited by 1
Self-citationT-cell commitment inheritance—an agent-based multi-scale model
Andersson, E., Rothenberg, E. V., Peterson, C., & Olariu, V. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00368-y · Cited by 1
Molecular Regulation of Granulopoiesis
Kumar, S., & Filippi, M. (2013) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781848168374_0001 · Cited by 1
Koschmieder, S., & Serve, H. L. (2007) · Wiley eBooks · doi:10.1002/9780470025079.chap387 · Cited by 1
Novak, K. D. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1770 · Cited by 1
Rathinam, C., & Klein, C. (2012) · PLoS ONE · doi:10.1371/annotation/4f75f09f-a8f0-4cae-b75f-30498d6b44d4 · Cited by 1
“1 [36,37], Gfi1 may be involved in the specification of distinct developmental fates in B cell differentiation.”
BackgroundRetractedThe Macrophage Epigenome and the Control of Inflammatory Gene Expression
Polletti, S., Curina, A., Natoli, G., & Ghisletti, S. (2014) · Epigenetics and human health · doi:10.1007/978-3-642-45198-0_15
WILMS’ TUMOUR GENE 1 PROTEIN (WT1) – AN EFFECTOR IN LEUKEMOGENESIS?
Vidovic, K. (2010) · Lund University Publications (Lund University)
Germline mutations in SPI1 and MADD do not contribute to familial chronic lymphocytic leukaemia
Sellick, G. S., Qureshi, M., Fielding, S., Catovsky, D., & Houlston, R. S. (2007) · Leukemia · doi:10.1038/sj.leu.2404646
Deciphering the Pathogenesis of Acute Myeloid Leukemia
Reckzeh, K. (2012) · Lund University Publications (Lund University)
Real, D. (2013) · CaltechTHESIS (California Institute of Technology) · doi:10.7907/pews-km18
Les progéniteurs multipotents exprimant Flt3 source des précurseurs T extra-thymiques
Zepponi, V. (2012) · theses.fr (ABES) · doi:10.70675/06b2b6fez3ce8z446dz84e1z5c08517e1a2d
EPIGENETIC SILENCING OF THE PROAPOPTOTIC GENE BIM IN ANAPLASTIC
Mogavero, A. (2010)
Vidovic, K. (2010)
Metadata
- Authors
- Rosenbauer, F., Owens, B. M., Yu, L., Tumang, J. R., Steidl, U., Kutok, J. L., Clayton, L. K., Wagner, K., Scheller, M., Iwasaki, H., Liu, C., Hackanson, B., Akashi, K., Leutz, A., Rothstein, T. L., Plass, C., & Tenen, D. G.
- Affiliations
- Harvard University (US)
- The Ohio State University (US)
- Boston University (US)
- Brigham and Women's Hospital (US)
- Leibniz University Hannover (DE)
- Max Delbrück Center (DE)
- Corresponding author
- Rosenbauer, Frank
- Tenen, Daniel G
- ORCID
- Venue
- Nature Genetics
- Published
- 2005-11-27
- Volume
- 38
- Issue
- 1
- Pages
- 27-37
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2100126911
- Cited by
- 237
- References
- 51
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 15 · 2023: 11 · 2022: 5 · 2021: 8 · 2020: 9 · 2019: 11 · 2018: 10 · 2017: 8 · 2016: 15 · 2015: 9 · 2014: 7 · 2013: 19 · 2012: 13
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- PU.1, upstream regulatory sequences, enhancers, transcriptional repression, T cell development, B cell development, acute myeloid leukemia, TCF transcription factors, Wnt signaling, DNA methylation, epigenetic silencing, tumor suppressor, cis-regulatory elements
- MeSH terms
- Proto-Oncogene Protein Spi-1, Animals, B-Lymphocytes, Cell Transformation, Neoplastic, Gene Expression Regulation, Lymphocytes, Mice, Transgenic, Promoter Regions, Genetic, Proto-Oncogene Proteins, Regulatory Sequences, Nucleic Acid, Stem Cells, Thymus Gland, Signal Transduction, Trans-Activators, Lymphoma, T-Cell, Mice, SCID, Thy-1 Antigens, DNA Methylation, Wnt Proteins, beta Catenin, Mice, TCF Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.